Effects Of Dietary Fats on Gut Microbiota Composition and Metabolic Activity in Healthy Adults
1 other identifier
interventional
64
1 country
1
Brief Summary
This study will investigate how adding a specific type of dietary fat to daily meals for two weeks affects the gut bacteria and their activity. Participants will be randomly assigned to consume one of four types of fat: butter, coconut oil, olive oil, or sunflower oil (60 mL each day for 2 weeks). Stool and blood samples (after an overnight fast) will be collected at 3 time points during the study (Days 1, 7, and 22). These samples will be used to measure metabolites produced by gut bacteria, the types of bacteria present in the gut, blood lipids, and inflammatory markers. The study, based on previous in vitro findings, aims to understand whether different types of fats (based on their structure and level of saturation) have different effects on gut bacteria and their activity in healthy subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 23, 2026
CompletedFirst Submitted
Initial submission to the registry
April 17, 2026
CompletedFirst Posted
Study publicly available on registry
April 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2028
April 24, 2026
April 1, 2026
1 year
April 17, 2026
April 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in faecal short-chain fatty acid (SCFA) concentrations
Faecal concentrations of short-chain fatty acids (acetate, propionate, and butyrate) will be measured using gas chromatography to assess changes in gut microbial metabolic activity in response to dietary fat intervention.
Day 1 (pre run-in), Day 7 (baseline, post run-in), and Day 22 (post-intervention)
Change in gut microbiota composition
Gut microbiota composition will be assessed using 16S rRNA gene amplicon sequencing to evaluate changes in bacterial diversity and relative abundance following the dietary fat intervention.
Day 1 (pre run-in), Day 7 (baseline, post run-in), and Day 22 (post-intervention)
Secondary Outcomes (5)
Change in blood lipid profile
Day 1 (pre run-in), Day 7 (baseline, post run-in), and Day 22 (post-intervention)
Change in inflammatory markers
Day 1 (pre run-in), Day 7 (baseline, post run-in), and Day 22 (post-intervention)
Change in faecal pH
Day 1 (pre run-in), Day 7 (baseline, post run-in), and Day 22 (post-intervention)
Change in fasting glucose concentrations
Day 1 (pre run-in), Day 7 (baseline, post run-in), and Day 22 (post-intervention)
Change in faecal fat content
Day 1 (pre run-in), Day 7 (baseline, post run-in), and Day 22 (post-intervention)
Study Arms (4)
Butter
EXPERIMENTALFollowing a one week run-in period (habitual diet), participants will be assigned to consume butter as their primary dietary fat.
Coconut Oil
EXPERIMENTALFollowing a one week run-in period (habitual diet), participants will be assigned to consume coconut oil as their primary dietary fat.
Extra Virgin Olive Oil
EXPERIMENTALFollowing a one week run-in period (habitual diet), participants will be assigned to consume olive oil as their primary dietary fat.
Sunflower Oil
EXPERIMENTALFollowing a one week run-in period (habitual diet), participants will be assigned to consume sunflower oil as their primary dietary fat.
Interventions
Participants will consume approximately 65 g/day of butter as their primary dietary fat for 14 days, replacing most habitual dietary fat intake.
Participants will consume approximately 55 g/day of coconut oil as their primary dietary fat for 14 days, replacing most habitual dietary fat intake.
Participants will consume 60 mL/day of olive oil as their primary dietary fat for 14 days, replacing most habitual dietary fat intake.
Participants will consume 60 mL/day of sunflower oil as their primary dietary fat for 14 days, replacing most habitual dietary fat intake.
Eligibility Criteria
You may qualify if:
- Adults aged 20-50 years
- Body mass index (BMI) between 20 and 30 kg/m²
- Generally healthy
- Stable body weight (±2 kg) over the past 2 months
- Living in the Glasgow area
- Non-smoker
You may not qualify if:
- Use of antibiotics within the past 3 months
- Current use of medications affecting gut microbiota or cardiometabolic health
- Regular use of dietary supplements that may influence study outcomes (e.g. probiotics, prebiotics, vitamins, minerals, fish oil), unless willing to discontinue prior to study start
- Presence of chronic gastrointestinal, metabolic, cardiovascular, hepatobiliary, or pancreatic disease
- History of major gastrointestinal surgery
- Diagnosed diabetes or use of lipid-lowering therapy
- Known fat malabsorption disorders
- Pregnant or lactating women
- Post-menopausal women
- Following a restrictive or specific diet (e.g. vegan, ketogenic diet)
- Food allergies or intolerances relevant to study interventions (e.g. dairy, coconut)
- Recent significant weight change (±2 kg in the past month)
- High reliance on ready meals or takeaway foods (\>7 main meals per week)
- Participation in another research study that may interfere with this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Glasgowlead
- Dr Dalia Malkovacollaborator
- Professor Konstantinos Gerasimidiscollaborator
Study Sites (1)
New Lister Building, Glasgow Royal Infirmary, 10-16 Alexandra Parade, G31 2ER
Glasgow, G31 2ER, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Athanasios Koutsos
University of Glasgow
- PRINCIPAL INVESTIGATOR
Dalia Malkova, PhD
University of Glasgow
- PRINCIPAL INVESTIGATOR
Konstantinos Gerasimidis, PhD
University of Glasgow
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer in Human Nutrition
Study Record Dates
First Submitted
April 17, 2026
First Posted
April 24, 2026
Study Start
March 23, 2026
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2028
Last Updated
April 24, 2026
Record last verified: 2026-04